The following commentary comes from an independent investor or market observer as part of TheStreet's guest contributor program, which is separate from the company's news coverage.NEW YORK ( ETF Expert) -- Abbott Laboratories ( ABT) sports five-year dividend growth of nearly 10% as well as a 3.5%+ annualized yield. Eli Lilly ( LLY) has a P/E of 9, a 5.3% dividend yield and three-year earnings growth of 19%. Meanwhile, AstraZeneca ( AZN) has a mammoth 35% trailing return on equity with a 5.8% annual dividend payout. How in the world are investors overlooking the pharma space? Actually, the smart money hasn't overlooked it. The iShares DJ Pharmaceuticals Fund ( IHE) is part of a select group of stock ETFs with a price above a 200-day moving average. In fact, not many stock ETFs in that select group can lay claim to year-to-date gains of about 8%.